MRSA bloodstream infections (% resistant)
78.0%
Source: World Health Organization, Global Health ObservatoryAs of 2023-12-31
Next steps
Public health
MRSA bloodstream infection resistance is classified Critical at 78.0%, observed through 2023-12-31. Assessment basis: MRSA bloodstream infections, not all antimicrobial resistance.
MRSA bloodstream infections (% resistant)
78.0%
Source: World Health Organization, Global Health ObservatoryAs of 2023-12-31
Assessment
Critical
BDPolicyLab analytical classification based on the stated assessment basis. It is not an official agency designation. Benchmark stress score: 95/100.
Source: BDPolicyLab assessmentAs of 2023-12-31
Movement
Unchanged
Current for source cadence
Source: BDPolicyLab comparable assessmentsAs of 24 Aug 2026, 04:25
Current for source cadence. Cadence basis: annual official series with publication lag.
Source: BDPolicyLab Crisis Orb Updated 2026-08-23
| Evidence | Reading | Observed through | Primary source |
|---|---|---|---|
| MRSA bloodstream infections (% resistant) | 78.0% | 2023-12-31 | World Health Organization, Global Health ObservatoryAMR_INFECT_MRSA |
Comparable assessments
Current movement: Unchanged
Critical
25 Jul 2026, 07:03 to 24 Aug 2026, 04:25
343 comparable assessments.
Decision architecture
These are linked records, not recommendations. They identify documented responsibility, published policy work, and modelled instruments that have passed their respective public gates.
Owns
Public health, family planning, medical education, and pharmaceutical regulation
Authority: Constitution of Bangladesh, Article 55; Rules of Business 1996
Owns
Principal drug regulatory agency responsible for drug regulation, pharmaceutical licensing, drug quality control, and enforcement of the Drugs Act
Authority: Drugs (Control) Ordinance 1982
Grounded prescription
Antimicrobial Resistance: Close the Over-the-Counter Tap Before Resistance Outruns the Drug PipelineBangladesh's AMR threat is driven by over-the-counter antibiotic sales and resistance building in pediatric and poultry use; DGHS should enforce prescription-only dispensing, stand up surveillance, and curb agricultural use before last-line drugs fail.
Research · Primary
Bangladesh Health System: Remarkable Gains, Persistent Gaps, and the Path to Universal CoverageResearch · Primary
Bangladesh Pharmaceutical Industry AnalysisResearch · Related
Child Nutrition in Bangladesh: BDHS 2022 EvidenceResearch · Primary
The State of Bangladesh HealthThe assessment compares the latest source observation with BDPolicyLab analytical monitoring bands. For this detector, higher readings indicate greater stress; the internal analytical cutoffs are 25.0%, 35.0%, 50.0%, 70.0%. The score is a level-anchored piecewise-linear transformation with state bands at 20, 40, 60, and 85. The indicator's primary source is identified with the evidence in this card. Forecast ranges are published only as calibrated 80% predictive intervals with an explicit source time unit.
BDPolicyLab analytical classification based on the stated assessment basis. It is not an official agency designation.
No public forecast is shown because the validation or time-unit requirement was not met.
Sources: World Health Organization, Global Health Observatory